查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585597

生物样本库市场：按组成部分、样本类型和应用划分 - 2025-2030 年全球预测

Biobanks Market by Component (Consumables, Equipment, Services), Sample Type (Biological Fluids, Blood Products, Cell Lines), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年生物样本库市场价值为678.1亿美元，预计到2024年将达到757.5亿美元，复合年增长率为11.80%，到2030年将达到1481亿美元。

生物样本库是收集和储存血液、细胞、组织和 DNA 等生物样本的重要储存库，主要用于研究和医学进展。对个人化医疗和基因组研究日益增长的需求强调了这一需求，因为它为疾病进展、药物开发和生物标记发现的研究提供了关键资料。生物样本库具有广泛的应用范围，包括学术研究机构、製药公司和医院，最终用途扩展到个人化医疗、癌症研究和再生医学。生物样本库市场受到基因组技术进步、政府对生物银行计划的资助以及生物製药公司对药物发现计划的投资增加等因素的影响。最新的潜在商机在于人工智慧和区块链等数位技术在资料管理和安全方面的整合。挑战包括资料隐私方面的道德问题、与生物样本库管理相关的高成本以及阻碍市场成长的监管复杂性。人们也担心生物样本库设施之间的样本储存品质和标准化。为了克服这些挑战，创新可以致力于改进冷冻保存技术，开发样本收集和储存的标准化通讯协定，并确保高品质和可重复的样本资料。此外，关键字之间的协力网路可以促进资源和知识共用，并促进研究和发展进展。该市场的特点是竞争激烈、技术发展迅速，需要持续投资研发以维持尖端能力。总体而言，由于技术整合和对个人化医疗的日益重视，生物样本库市场具有巨大的成长潜力，战略联盟和增强的资料安全性是成功的关键。

主要市场统计
基准年[2023] 678.1亿美元
预测年份 [2024] 757.5亿美元
预测年份 [2030] 1,481亿美元
复合年增长率（%） 11.80%

市场动态：揭示快速发展的生物样本库市场的关键市场洞察

供需的动态交互作用正在改变生物样本库市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 慢性病盛行率增加
    • 人们对生物样本库的认识不断增强
    • 人口成长加上大量老化人口基数的存在
  • 市场限制因素
    • 有关生物银行的伦理和法律问题
  • 市场机会
    • 各国基因组研究活动的活性化
    • 提高大众对基因组测试和干细胞治疗的认识
  • 市场挑战
    • 生物样本库的长期永续性

波特五力：驾驭生物样本库市场的策略工具

波特的五力架构是了解生物样本库市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解生物样本库市场的外部影响

外部宏观环境因素在塑造生物样本库市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解生物样本库市场的竞争状况

对生物样本库市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵生物样本库市场供应商的绩效评估

FPNV定位矩阵是评估生物样本库市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了生物样本库市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，生物样本库市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病发生率增加
      • 提高生物样本库的意识
      • 人口增长和大量老年人口基数的存在
    • 抑制因素
      • 与生物银行相关的道德和法律问题
    • 机会
      • 扩大基因组研究活动在经济的应用
      • 意识提升
    • 任务
      • 生物样本库的长期永续性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章生物样本库市场：依组成部分

  • 消耗品
  • 装置
  • 服务
  • 软体

第七章依样本类型分類的生物样本库市场

  • 体液
  • 血液製品
  • 细胞株
  • 人体组织
  • 核酸

第八章生物样本库市场：依应用分类

  • 临床调查
  • 生命科学研究
  • 再生医学

第九章美洲生物样本库市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太生物样本库市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲生物样本库市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Acorn Biolabs, Inc.
  • Artizan Biosciences, Inc.
  • Bay Biosciences LLC
  • Beckman Coulter, Inc. by Danaher Corporation
  • Becton, Dickinson and Company
  • BioLife Solutions Inc.
  • LVL Technologies GmbH & Co. KG
  • Merck KGaA
  • ProteoGenex, Inc.
  • Provia Laboratories, LLC
  • Shanghai Zhangjiang Biobank
  • Taylor-Wharton
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • UK Biobank Limited
Product Code: MRR-437D4595886E

The Biobanks Market was valued at USD 67.81 billion in 2023, expected to reach USD 75.75 billion in 2024, and is projected to grow at a CAGR of 11.80%, to USD 148.10 billion by 2030.

Biobanks are crucial repositories that collect and store biological samples such as blood, cells, tissues, and DNA, predominantly for research and medical advancements. Their necessity is underscored by the increasing demand for personalized medicine and genomic research, as they provide critical data for studies on disease progression, drug development, and biomarker discovery. The application of biobanks spans across academic research institutions, pharmaceutical companies, and hospital settings, with a growing end-use scope in personalized healthcare, cancer research, and regenerative medicine. The market for biobanks is influenced by factors such as advances in genomic technologies, government funding for biobanking projects, and growing investments by biopharma companies in drug discovery initiatives. The latest potential opportunities lie in the integration of digital technologies like artificial intelligence and blockchain for data management and security-allowing more efficient sample tracking and usage, which can significantly enhance research outputs. Challenges include ethical concerns over data privacy, high costs associated with biobank management, and regulatory complexities which can impede market growth. There are also concerns over sample storage quality and standardization across biobanking facilities. To overcome these challenges, innovation can be directed towards improving cryopreservation techniques and developing standardized protocols for sample collection and storage to ensure high-quality and reproducible sample data. Additionally, collaborative networks among biobanks can facilitate the sharing of resources and knowledge, fostering advancements in research and development. The market is characterized by high competition and rapid technological evolution, necessitating continuous investment in R&D to maintain cutting-edge capabilities. Overall, the biobank market holds significant potential for growth driven by technological integration and a growing emphasis on personalized medicine, with strategic collaborations and enhanced data security being pivotal for success.

KEY MARKET STATISTICS
Base Year [2023] USD 67.81 billion
Estimated Year [2024] USD 75.75 billion
Forecast Year [2030] USD 148.10 billion
CAGR (%) 11.80%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biobanks Market

The Biobanks Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in incidence of chronic disease
    • Rising awareness about biobanks
    • Increasing population coupled with presence of a large geriatric population base
  • Market Restraints
    • Ethical and legal issues related to biobanking
  • Market Opportunities
    • Growing genomic research activities in economies
    • Increasing public awareness about genomic testing and stem cell therapies
  • Market Challenges
    • Long-Term Sustainability of Biobanks

Porter's Five Forces: A Strategic Tool for Navigating the Biobanks Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biobanks Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biobanks Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biobanks Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biobanks Market

A detailed market share analysis in the Biobanks Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biobanks Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biobanks Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biobanks Market

A strategic analysis of the Biobanks Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biobanks Market, highlighting leading vendors and their innovative profiles. These include Acorn Biolabs, Inc., Artizan Biosciences, Inc., Bay Biosciences LLC, Beckman Coulter, Inc. by Danaher Corporation, Becton, Dickinson and Company, BioLife Solutions Inc., LVL Technologies GmbH & Co. KG, Merck KGaA, ProteoGenex, Inc., Provia Laboratories, LLC, Shanghai Zhangjiang Biobank, Taylor-Wharton, Tecan Trading AG, Thermo Fisher Scientific Inc., and UK Biobank Limited.

Market Segmentation & Coverage

This research report categorizes the Biobanks Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Component, market is studied across Consumables, Equipment, Services, and Software.
  • Based on Sample Type, market is studied across Biological Fluids, Blood Products, Cell Lines, Human Tissues, and Nucleic Acids.
  • Based on Application, market is studied across Clinical Research, Life Science Research, and Regenerative Medicine.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in incidence of chronic disease
      • 5.1.1.2. Rising awareness about biobanks
      • 5.1.1.3. Increasing population coupled with presence of a large geriatric population base
    • 5.1.2. Restraints
      • 5.1.2.1. Ethical and legal issues related to biobanking
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing genomic research activities in economies
      • 5.1.3.2. Increasing public awareness about genomic testing and stem cell therapies
    • 5.1.4. Challenges
      • 5.1.4.1. Long-Term Sustainability of Biobanks
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biobanks Market, by Component

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Equipment
  • 6.4. Services
  • 6.5. Software

7. Biobanks Market, by Sample Type

  • 7.1. Introduction
  • 7.2. Biological Fluids
  • 7.3. Blood Products
  • 7.4. Cell Lines
  • 7.5. Human Tissues
  • 7.6. Nucleic Acids

8. Biobanks Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical Research
  • 8.3. Life Science Research
  • 8.4. Regenerative Medicine

9. Americas Biobanks Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Biobanks Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Biobanks Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Acorn Biolabs, Inc.
  • 2. Artizan Biosciences, Inc.
  • 3. Bay Biosciences LLC
  • 4. Beckman Coulter, Inc. by Danaher Corporation
  • 5. Becton, Dickinson and Company
  • 6. BioLife Solutions Inc.
  • 7. LVL Technologies GmbH & Co. KG
  • 8. Merck KGaA
  • 9. ProteoGenex, Inc.
  • 10. Provia Laboratories, LLC
  • 11. Shanghai Zhangjiang Biobank
  • 12. Taylor-Wharton
  • 13. Tecan Trading AG
  • 14. Thermo Fisher Scientific Inc.
  • 15. UK Biobank Limited

LIST OF FIGURES

  • FIGURE 1. BIOBANKS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOBANKS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOBANKS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOBANKS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOBANKS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BIOBANKS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BIOBANKS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BIOBANKS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BIOBANKS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BIOBANKS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BIOBANKS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOBANKS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOBANKS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOBANKS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOBANKS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOBANKS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOBANKS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOBANKS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOBANKS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOBANKS MARKET SIZE, BY BIOLOGICAL FLUIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOBANKS MARKET SIZE, BY BLOOD PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOBANKS MARKET SIZE, BY CELL LINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOBANKS MARKET SIZE, BY HUMAN TISSUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOBANKS MARKET SIZE, BY NUCLEIC ACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOBANKS MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOBANKS MARKET SIZE, BY LIFE SCIENCE RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOBANKS MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES BIOBANKS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. BIOBANKS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 150. BIOBANKS MARKET, FPNV POSITIONING MATRIX, 2023